XGN
Exagen Inc

567
Mkt Cap
$73.84M
Volume
154,705.00
52W High
$12.23
52W Low
$2.91
PE Ratio
-3.34
XGN Fundamentals
Price
$3.07
Prev Close
$3.16
Open
$3.16
50D MA
$4.15
Beta
1.14
Avg. Volume
409,140.42
EPS (Annual)
-$0.9254
P/B
4.03
Rev/Employee
$308,217.59
$126.52
Loading...
Loading...
News
all
press releases
Exagen (NASDAQ:XGN) Downgraded by Wall Street Zen to Sell
Wall Street Zen cut Exagen from a "hold" rating to a "sell" rating in a report on Saturday...
MarketBeat·2d ago
News Placeholder
More News
News Placeholder
Canaccord Genuity Group Issues Pessimistic Forecast for Exagen (NASDAQ:XGN) Stock Price
Canaccord Genuity Group dropped their price objective on shares of Exagen from $15.00 to $10.00 and set a "buy" rating on the stock in a report on Wednesday...
MarketBeat·4d ago
News Placeholder
Exagen (NASDAQ:XGN) Price Target Cut to $10.00 by Analysts at Craig Hallum
Craig Hallum decreased their price objective on shares of Exagen from $12.00 to $10.00 and set a "buy" rating for the company in a research report on Wednesday...
MarketBeat·4d ago
News Placeholder
KeyCorp Issues Pessimistic Forecast for Exagen (NASDAQ:XGN) Stock Price
KeyCorp cut their price target on Exagen from $15.00 to $10.00 and set an "overweight" rating for the company in a research note on Wednesday...
MarketBeat·4d ago
News Placeholder
Exagen (NASDAQ:XGN) Price Target Lowered to $9.00 at BTIG Research
BTIG Research cut their price target on shares of Exagen from $10.00 to $9.00 and set a "buy" rating for the company in a report on Tuesday...
MarketBeat·5d ago
News Placeholder
Exagen Q4 Earnings Call Highlights
Exagen (NASDAQ:XGN) executives said the company closed 2025 with record revenue and testing volume, pointing to progress from operational changes made over the past several years, while acknowledging...
MarketBeat·5d ago
News Placeholder
Exagen Inc. (XGN) Reports Q4 Loss, Beats Revenue Estimates
Exagen (XGN) delivered earnings and revenue surprises of 0.00% and +1.62%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·5d ago
News Placeholder
Myomo, Inc. (MYO) Reports Q4 Loss, Tops Revenue Estimates
Myomo (MYO) delivered earnings and revenue surprises of +5.88% and +11.86%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·6d ago
News Placeholder
Exagen (NASDAQ:XGN) CEO John Aballi Sells 15,698 Shares
Exagen Inc. (NASDAQ:XGN - Get Free Report) CEO John Aballi sold 15,698 shares of the stock in a transaction that occurred on Tuesday, March 3rd. The stock was sold at an average price of $3.62, for a...
MarketBeat·10d ago
News Placeholder
Exagen Inc. (NASDAQ:XGN) Receives Average Rating of "Moderate Buy" from Analysts
Exagen Inc. (NASDAQ:XGN - Get Free Report) has earned a consensus rating of "Moderate Buy" from the ten research firms that are presently covering the company, MarketBeat Ratings reports. One analyst...
MarketBeat·11d ago
<
1
2
...
>

Latest XGN News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.